Dimitris Tsoukalas is currently the medical director of the Metabolomic Medicine® Medical Group. He is an Associate Member of the World Academy of Sciences and the President of the European Institute of Molecular Medicine, EINUMM. He graduated from the Universita’ degli Studi di Napoli, Federico II, Medical School, in 1991. He completed his Specialty in General & Family Medicine at the Hippokration University Hospital in 2000 and was awarded the highest recognition and Honorable Mention by the Greek Ministry of Health, for his contribution to Primary Health Care. Since 2012, he has been honored to work as President of the European Institute of Molecular Medicine. He completed the Harvard Medical School Update Course in General & Internal Medicine for subspecialists in 2013. He was a member of the scientific council of Farsight Bioscience together with Prof. Dr. Andrew David Miller of Kings College London. Since 2007, Dr. Dimitris Tsoukalas and his team have been working on the clinical applications of metabolomics analysis in autoimmune and chronic diseases. Their current research endeavors are centered around the use of metabolomics biomarkers in clinical practice, the field of telomere biology, and the effect of nutraceuticals on telomere length.
Dimitris Tsoukalas is currently the medical director of the Metabolomic Medicine® Medical Group. He is an Associate Member of the World Academy of Sciences and the President of the European Institute of Molecular Medicine, EINUMM. He graduated from the Universita’ degli Studi di Napoli, Federico II, Medical School, in 1991. He completed his Specialty in General & Family Medicine at the Hippokration University Hospital in 2000 and was awarded the highest recognition and Honorable Mention by the Greek Ministry of Health, for his contribution to Primary Health Care. Since 2012, he has been honored to work as President of the European Institute of Molecular Medicine. He completed the Harvard Medical School Update Course in General & Internal Medicine for subspecialists in 2013. He was a member of the scientific council of Farsight Bioscience together with Prof. Dr. Andrew David Miller of Kings College London. Since 2007, Dr. Dimitris Tsoukalas and his team have been working on the clinical applications of metabolomics analysis in autoimmune and chronic diseases. Their current research endeavors are centered around the use of metabolomics biomarkers in clinical practice, the field of telomere biology, and the effect of nutraceuticals on telomere length.